Showing results (271-280 of 398) with videos related to

Sort By:
Pageof 40
American Heart Journal|February 3, 2009
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)Adrian F Hernandez, Christopher M O'Connor, Randall C Starling, et al.
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
European Journal of Heart Failure|March 17, 2021
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaireAlice Ravera, Bernadet T Santema, Iziah E Sama, et al.
JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
Vaccine|June 19, 2007
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKent E Kester, Denise A McKinney, Nadia Tornieporth, et al.
The New England Journal of Medicine|November 12, 2013
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney diseaseDick de Zeeuw, Tadao Akizawa, Paul Audhya, et al.
Vaccine|January 4, 2006
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaJosé A Stoute, Joash Gombe, Mark R Withers, et al.
Vaccine|April 23, 2003
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative studyGeoffrey J Gorse, Theresa Z O'Connor, Stephen L Young, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
JACC. Heart Failure|September 7, 2023
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF RegistryJasper Tromp, Justin A Ezekowitz, Wouter Ouwerkerk, et al.
Pageof 40